Animal models of ischemic stroke are procedures inducing cerebral ischemia. The aim is the study of basic processes or potential therapeutic interventions in this disease, and the extension of the pathophysiological knowledge on and/or the improvement of medical treatment of human ischemic stroke.
Ischemic stroke has a complex pathophysiology involving the interplay of many different cells and tissues such as neurons, glia, endothelium, and the immune system. These events cannot be mimicked satisfactorily in vitro yet. Thus a large portion of stroke research is conducted on animals.
=Overview=
Several models in different species are currently known to produce cerebral ischemia. Global ischemia models, both complete and incomplete, tend to be easier to perform. However, they are less immediately relevant to human stroke than the focal stroke models, because global ischemia is not a common feature of human stroke. However, in various settings global ischemia is also relevant, e.g. in global anoxic brain damage due to cardiac arrest. Different species also vary in their susceptibility to the various types of ischemic insults. An example is gerbils. They do not have a Circle of Willis and stroke can be induced by common carotid artery occlusion alone.
Mechanisms of inducing ischemic stroke
Some of the mechanisms which have been used are:
- Complete global ischemia
- Decapitation
- Aorta/vena cava occlusion
- External neck torniquet or cuff
- Carotid artery occlusion
- Cardiac arrest
- Incomplete global ischemia
- Hemorrhage or hypotension
- Hypoxic ischemia
- Intracranial hypertension and common carotid artery occlusion
- Two-vessel occlusion and hypotension
- Four-vessel occlusion
- Unilateral common carotid artery occlusion (in some species only)
- Focal cerebral ischemia
- Middle cerebral artery occlusion
- Spontaneous brain infarction (in spontaneously hypertensive rats)
- Macrosphere embolization
- Multifocal cerebral ischemia
- Blood clot embolization
- Microsphere embolization
- Photothrombosis
Focal ischemia models
They are divided into techniques including
reperfusion of the ischemic tissue (transient focal cerebral ischemia) and those without reperfusion (permanent focal cerebral ischemia). The following models are established :
- Middle cerebral artery occlusion (MCAO)
- MCAO avoiding craniotomy
- Embolic middle cerebral artery occlusion
- Endovascular filament middle cerebral artery occlusion (transient or permanent)
- MCAO involving craniotomy
- Permanent transcranial middle cerebral artery occlusion
- Transient transcranial middle cerebral artery occlusion
- Direct tissue damage
- Cerebrocortical photothrombosis
Embolic middle cerebral artery occlusion
Middle cerebral artery (MCA) occlusion is achieved in this model by injecting particles like blood clots (thrombembolic MCAO) or artificial spheres into the carotid artery of animals as an
animal model of ischemic stroke. Thromembolic MCAO is achieved either by injecting clots that were formed in vitro or by endovascular instillation of
thrombin for in situ clotting . The thrombembolic model is closest to the pathophysiology of human
cardioembolic stroke. When injecting spheres into the cerebral circulation, their size determines the pattern of brain infarction: Macrospheres (300 – 400 µm) induce infarcts similar to those achieved by occlusion of the proximal MCA , whereas microsphere (~ 50 µm) injection results in distal, diffuse embolism . However, the quality of MCAO – and thus the volume of brain
infarcts – is very variable, a fact which is further aggravated by a certain rate of spontaneous
lysis of injected blood clots.
Endovascular filament middle cerebral artery occlusion
The technique of endovascular filament (intraluminal suture) MCAO as an
animal model of ischemic stroke was described first by Koizumi . It is applied to rats and mice. A piece of surgical filament is introduced into the
internal carotid artery and forwarded until the tip occludes the origin of the
middle cerebral artery, resulting in a cessation of blood flow and subsequent brain
infarction in its area of supply. If the suture is removed after a certain interval, reperfusion is achieved (transient MCAO); if the filament is left in place the procedure is suitable as model of permanent MCAO, too. The most common modification is based on Longa (1989) who described filament introduction via the
external carotid artery, allowing closure of the access point with preserved blood supply via the
common and internal carotid artery to the brain after the removal of the filament. Known pitfalls of this method are insufficient occlusion,
subarachnoid hemorrhage ,
hyperthermia , and
necrosis of the ipsilateral extracranial tissue . Filament MCAO is not applicable to all rat
strains .
Permanent transcranial middle cerebral artery occlusion
In this
animal model of ischemic stroke the
middle cerebral artery (MCA) is surgically dissected and subsequently permanently occluded, e.g. by
electrocautery or
ligation. Occlusion can be performed on the proximal or distal part of the MCA. In the latter, ischemic damage is restricted to the cerebral
cortex. MCAO can be combined with temporal or permanent
common carotid artery occlusion. These models require
craniotomy and, thus, are relatively invasive.
Transient transcranial middle cerebral artery occlusion
The technique of modeling
ischemic stroke by transient transcranial MCAO is similar to that of permanent transcranial MCAO, with the
MCA being reperfused after a defined period of
focal cerebral ischemia . Like permanent MCAO, craniotomy is required and
common carotid artery (CCA) occlusion can be combined. Occluding one MCA and both CCAs is referred to as the three vessel occlusion model of
focal cerebral ischemia.
Cerebrocortical photothrombosis
Photothrombotic
models of ischemic stroke use local intravascular photocoagulation of circumscribed cortical areas. After intravenous injection of photosensitive dyes like
rose-bengal, the brain is irradiated with through the intact skull, leading to photochemical occlusion of the irradiated vessels with secondary tissue ischemia .
See also
References
Animal experimentation